Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Vassall

Showing results (101-110 of 167) with videos related to

Pageof 17
Sort By:
Cost Effectiveness and Resource Allocation : C/E|October 9, 2023
The use of cost-effectiveness analysis for health benefit package design - should countries follow a sectoral, incremental or hybrid approach?Rob Baltussen, Gavin Surgey, Anna Vassall, et al.
International Journal of Health Policy and Management|August 5, 2024
Assessing Global Evidence on Cost-Effectiveness to Inform Development of Pakistan's Essential Package of Health ServicesMaryam Huda, Nichola Kitson, Nuru Saadi, et al.
Trials|April 16, 2015
Evaluation of a point-of-care tuberculosis test-and-treat algorithm on early mortality in people with HIV accessing antiretroviral therapy (TB Fast Track study): study protocol for a cluster randomised controlled trialKatherine L Fielding, Salome Charalambous, Christopher J Hoffmann, et al.
Plos One|December 31, 2015
The Impact and Cost-Effectiveness of a Four-Month Regimen for First-Line Treatment of Active Tuberculosis in South AfricaGwenan M Knight, Gabriela B Gomez, Peter J Dodd, et al.
The Lancet. Global Health|October 12, 2014
Cost-effectiveness of HIV prevention for high-risk groups at scale: an economic evaluation of the Avahan programme in south IndiaAnna Vassall, Michael Pickles, Sudhashree Chandrashekar, et al.
Wellcome Open Research|September 12, 2022
Integrating economic and health evidence to inform Covid-19 policy in low- and middle- income countriesAnna Vassall, Sedona Sweeney, Edwine Barasa, et al.
Plos One|November 27, 2018
Variation in the quality and out-of-pocket cost of treatment for childhood malaria, diarrhoea, and pneumonia: Community and facility based care in rural UgandaSeyi Soremekun, Frida Kasteng, Raghu Lingam, et al.
PLOS Global Public Health|March 24, 2023
Estimating waiting times, patient flow, and waiting room occupancy density as part of tuberculosis infection prevention and control research in South African primary health care clinicsAaron S Karat, Nicky McCreesh, Kathy Baisley, et al.
Epidemics|August 10, 2024
Improving the contribution of mathematical modelling evidence to guidelines and policy: Experiences from tuberculosisC Finn McQuaid, Nicolas A Menzies, Rein M G J Houben, et al.
Plos One|January 23, 2016
Innovation in Evaluating the Impact of Integrated Service-Delivery: The Integra Indexes of HIV and Reproductive Health IntegrationSusannah H Mayhew, George B Ploubidis, Andy Sloggett, et al.
Pageof 17

Showing results (101-110 of 167) with videos related to

Sort By:
Pageof 17
Cost Effectiveness and Resource Allocation : C/E|October 9, 2023
The use of cost-effectiveness analysis for health benefit package design - should countries follow a sectoral, incremental or hybrid approach?Rob Baltussen, Gavin Surgey, Anna Vassall, et al.
International Journal of Health Policy and Management|August 5, 2024
Assessing Global Evidence on Cost-Effectiveness to Inform Development of Pakistan's Essential Package of Health ServicesMaryam Huda, Nichola Kitson, Nuru Saadi, et al.
Trials|April 16, 2015
Evaluation of a point-of-care tuberculosis test-and-treat algorithm on early mortality in people with HIV accessing antiretroviral therapy (TB Fast Track study): study protocol for a cluster randomised controlled trialKatherine L Fielding, Salome Charalambous, Christopher J Hoffmann, et al.
Plos One|December 31, 2015
The Impact and Cost-Effectiveness of a Four-Month Regimen for First-Line Treatment of Active Tuberculosis in South AfricaGwenan M Knight, Gabriela B Gomez, Peter J Dodd, et al.
The Lancet. Global Health|October 12, 2014
Cost-effectiveness of HIV prevention for high-risk groups at scale: an economic evaluation of the Avahan programme in south IndiaAnna Vassall, Michael Pickles, Sudhashree Chandrashekar, et al.
Wellcome Open Research|September 12, 2022
Integrating economic and health evidence to inform Covid-19 policy in low- and middle- income countriesAnna Vassall, Sedona Sweeney, Edwine Barasa, et al.
Plos One|November 27, 2018
Variation in the quality and out-of-pocket cost of treatment for childhood malaria, diarrhoea, and pneumonia: Community and facility based care in rural UgandaSeyi Soremekun, Frida Kasteng, Raghu Lingam, et al.
PLOS Global Public Health|March 24, 2023
Estimating waiting times, patient flow, and waiting room occupancy density as part of tuberculosis infection prevention and control research in South African primary health care clinicsAaron S Karat, Nicky McCreesh, Kathy Baisley, et al.
Epidemics|August 10, 2024
Improving the contribution of mathematical modelling evidence to guidelines and policy: Experiences from tuberculosisC Finn McQuaid, Nicolas A Menzies, Rein M G J Houben, et al.
Plos One|January 23, 2016
Innovation in Evaluating the Impact of Integrated Service-Delivery: The Integra Indexes of HIV and Reproductive Health IntegrationSusannah H Mayhew, George B Ploubidis, Andy Sloggett, et al.
Pageof 17